M
Melanie Marti
Researcher at World Health Organization
Publications - 11
Citations - 786
Melanie Marti is an academic researcher from World Health Organization. The author has contributed to research in topics: Medicine & Systematic review. The author has an hindex of 4, co-authored 6 publications receiving 395 citations.
Papers
More filters
Journal ArticleDOI
Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015-2017.
TL;DR: The World Health Organization's vaccine hesitancy definition understood; >90% countries report Hesitancy; long list of reasons, varied by country income level; WHO region, changed overtime.
Journal ArticleDOI
Global Varicella Vaccine Effectiveness: A Meta-analysis
TL;DR: One dose of varicella vaccine was moderately effective in preventing allvaricella and highly effective in Preventing moderate/severe variceella, with no differences by vaccine.
Journal ArticleDOI
Assessments of global drivers of vaccine hesitancy in 2014—Looking beyond safety concerns
TL;DR: The proposed indicators provide the first global snapshot of reasons driving vaccine hesitancy and depicting its widespread nature, as well as the extent of assessments conducted by countries.
letters-and-commentsDOI
Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review
Edward P.K. Parker,Shalini Desai,Melanie Marti,Hanna Nohynek,David C. Kaslow,Sonali Kochhar,Katherine L. O’Brien,Joachim Hombach,Annelies Wilder-Smith +8 more
Journal ArticleDOI
Efficacy and safety of COVID‐19 vaccines
Carolina Graña,Lina Ghosn,Theodoros Evrenoglou,Alexander Jarde,Silvia Minozzi,Hanna Bergman,Brian S Buckley,Katrin Probyn,Gemma Villanueva,Nicholas Henschke,H. Bonnet,Rouba Assi,Sonia Menon,Melanie Marti,Declan Devane,P. Mallon,Jean-Daniel Lelièvre,Lisa M. Askie,Tamara Kredo,Gabriel Ferrand,Mauricia Davidson,Carolina Riveros,David Tovey,Joerg J Meerpohl,Giacomo Grasselli,Gabriel Zada,Asbjørn Hróbjartsson,Philippe Ravaud,Anna Chaimani,Isabelle Boutron +29 more
TL;DR: In this paper , the authors evaluated the efficacy and safety of COVID-19 vaccines against SARS-CoV•2 virus and concluded that they probably reduce the risk of all-cause mortality (risk ratio (RR) 0.25, 95% CI 0.09 to 0.67.